Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pituitary Neuroendocrine Tumors”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableStudy completedNCT06253897
What this trial is testing

Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorAcromegaly
Ipsen 20
Early research (Phase 1)Ended earlyNCT05364944
What this trial is testing

Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Who this might be right for
AcromegalyGEP-NET
Debiopharm International SA 19
Early research (Phase 1)Study completedNCT00446082
What this trial is testing

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Who this might be right for
Carcinoid TumorAcromegaly
Novartis Pharmaceuticals 85
Not applicableActive Not RecruitingNCT03583528
What this trial is testing

DOTATOC PET/CT for Imaging NET Patients

Who this might be right for
Neuroendocrine TumorsInsulinomaGastrinoma+13 more
British Columbia Cancer Agency 800
Not applicableLooking for participantsNCT05254197
What this trial is testing

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

Who this might be right for
Brain Tumor, PrimaryMeningiomaSchwannoma+2 more
Seoul National University Hospital 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118
Not applicableStudy completedNCT01840449
What this trial is testing

Somatuline Predictive Factors in Acromegaly and NET

Who this might be right for
AcromegalyNeuroendocrine Tumours
Ipsen 156
Not applicableNot Yet RecruitingNCT06326853
What this trial is testing

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Who this might be right for
Endocrine DisordersAdiposityPituitary Adenoma+3 more
IRCCS San Raffaele 200
Post-approval studies (Phase 4)Looking for participantsNCT04081701
What this trial is testing

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

Who this might be right for
CNS TumorsMeningiomaEsthesioneuroblastoma+4 more
Weill Medical College of Cornell University 200
Not applicableLooking for participantsNCT05139277
What this trial is testing

Evaluation of the CONVIVO System

Who this might be right for
GlioblastomaGlial TumorBrain Metastases+3 more
Dartmouth-Hitchcock Medical Center 30
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableNot Yet RecruitingNCT07809178
What this trial is testing

China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm

Who this might be right for
Unruptured Intracranial AneurysmsPituitary Neuroendocrine TumorCraniopharyngioma+6 more
Cheng sen 608
Early research (Phase 1)Study completedNCT04212793
What this trial is testing

Detection of PitNET Tissue During TSS Using Bevacizumab-800CW

Who this might be right for
Pituitary TumorPituitary AdenomaPituitary Macroadenoma
University Medical Center Groningen 20
Very early researchLooking for participantsNCT07493447
What this trial is testing

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Who this might be right for
MeningiomaGlioblastomaAcoustic Neuroma+2 more
Eben Rosenthal 30
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Not applicableStudy completedNCT01556230
What this trial is testing

Prospective Study of Clinically Nonfunctioning Pituitary Adenomas

Who this might be right for
Pituitary AdenomaPituitary Tumor
Columbia University 292
Testing effectiveness (Phase 2)Study completedNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 20
Post-approval studies (Phase 4)Study completedNCT01794793
What this trial is testing

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Who this might be right for
Cushing's DiseaseAcromegalyNeuroendocrine Tumors+6 more
RECORDATI GROUP 337
Post-approval studies (Phase 4)Looking for participantsNCT06679816
What this trial is testing

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

Who this might be right for
Pituitary AdenomaPituitary Neuroendocrine Tumor
Beijing Tiantan Hospital 882
Testing effectiveness (Phase 2)WithdrawnNCT04106843
What this trial is testing

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Who this might be right for
Locally Advanced Adrenal Gland PheochromocytomaLocally Advanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+11 more
M.D. Anderson Cancer Center
Next Page